drugset / Trial / NCT01606579
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
Non-randomizedParallel-groupOpen-labelTreatment
Summary
PRI-724 is a new investigational drug being studied to treat subjects with cancer who have advanced myeloid malignancies. PRI-724 is thought to work by blocking the Wnt signaling pathway that cancer cells need to grow and spread (metastasize).
Timeline
- Start
- 2012-07
- Primary completion
- 2016-12-30
- Completion
- 2016-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRI-724 | Small molecule | — | Intravenous |